News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current SLS market cap is 68.02M. The company's latest EPS is USD -0.6465 and P/E is -1.79.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.28M | -9.05M | -9.36M | -8.18M | -9.65M |
| Net Income | -11.1M | -8.84M | -9.27M | -8.14M | -9.57M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 1.9M | 7.6M | 1M | 0 |
| Operating Income | -20.04M | -16.98M | -19.59M | -41.95M | -37.87M |
| Net Income | -27.95M | -16.76M | -20.7M | -41.3M | -37.34M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 29.1M | 18.57M | 8.09M | 6.22M | 24.43M |
| Total Liabilities | 15.94M | 13.72M | 11.91M | 14.2M | 14.75M |
| Total Equity | 13.17M | 4.84M | -3.83M | -7.98M | 9.68M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 16.61M | 46.05M | 26.28M | 20.94M | 6.22M |
| Total Liabilities | 10.52M | 18.09M | 5.93M | 16.09M | 14.2M |
| Total Equity | 6.09M | 27.96M | 20.35M | 4.85M | -7.98M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.13M | -19.69M | -26.59M | -31.41M | -10.76M |
| Investing | N/A | -2.5M | -5.5M | -5.5M | N/A |
| Financing | 18.9M | 18.88M | 18.93M | 22.32M | 26.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.64M | -10.42M | -26.02M | -23.81M | -31.41M |
| Investing | N/A | N/A | N/A | -4.5M | -5.5M |
| Financing | 19.57M | 38.44M | 12.07M | 24.08M | 22.32M |
| Market Cap | 68.02M |
| Price to Earnings Ratio | -1.79 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 26.48 |
| Price to Book Ratio | -8.4 |
| Dividend Yield | - |
| Shares Outstanding | 57.75M |
| Average Volume (1 week) | 824.44k |
| Average Volume (1 Month) | 735.5k |
| 52 Week Change | -26.39% |
| 52 Week High | 1.90 |
| 52 Week Low | 0.4986 |
| Spread (Intraday) | 0.01 (0.85%) |
| Company Name | SELLAS Life Sciences Group Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.sellaslifesciences.com/home/default.aspx |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
